1. Home
  2. ONB vs RGEN Comparison

ONB vs RGEN Comparison

Compare ONB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old National Bancorp

ONB

Old National Bancorp

HOLD

Current Price

$23.44

Market Cap

8.9B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.75

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONB
RGEN
Founded
1834
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ONB
RGEN
Price
$23.44
$166.75
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$26.09
$174.90
AVG Volume (30 Days)
2.9M
701.7K
Earning Date
01-20-2026
10-28-2025
Dividend Yield
2.40%
N/A
EPS Growth
2.73
N/A
EPS
1.69
0.03
Revenue
$2,110,915,000.00
$707,890,000.00
Revenue This Year
$45.73
$17.84
Revenue Next Year
$14.53
$12.57
P/E Ratio
$13.79
$6,381.36
Revenue Growth
20.70
11.74
52 Week Low
$16.83
$102.97
52 Week High
$24.49
$182.52

Technical Indicators

Market Signals
Indicator
ONB
RGEN
Relative Strength Index (RSI) 68.06 60.24
Support Level $22.70 $156.01
Resistance Level $23.55 $165.02
Average True Range (ATR) 0.44 4.71
MACD 0.05 -0.46
Stochastic Oscillator 91.34 80.61

Price Performance

Historical Comparison
ONB
RGEN

About ONB Old National Bancorp

Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: